UK markets open in 2 hours 21 minutes

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.5360-0.0240 (-0.94%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
755
755
19,171
30,346
51,057
Cost of revenue
737
737
1,772
1,844
1,951
Gross profit
18
18
17,399
28,502
49,106
Operating expenses
Research development
87,646
87,646
97,501
117,840
77,048
Selling general and administrative
16,812
16,812
17,494
22,882
22,514
Total operating expenses
97,320
97,320
107,065
131,984
91,418
Operating income or loss
-97,302
-97,302
-89,666
-103,482
-42,312
Interest expense
5,307
5,307
3,787
4,171
2,407
Total other income/expenses net
-16,352
-16,352
6,060
9,741
-10,590
Income before tax
-116,466
-116,466
-98,600
-96,752
-53,582
Income tax expense
371
371
87
0
0
Income from continuing operations
-116,835
-116,835
-98,688
-96,749
-53,581
Net income
-101,059
-101,059
-106,139
-114,197
-81,074
Net income available to common shareholders
-101,059
-101,059
-106,139
-114,197
-81,074
Basic EPS
-1.66
-
-2.33
-2.55
-1.91
Diluted EPS
-1.66
-
-2.33
-2.55
-1.91
Basic average shares
52,088
-
45,547
44,820
42,503
Diluted average shares
52,088
-
45,547
44,820
42,503